Chemoinformaics analysis of 6-Methyl-2-(4-methylphenyl)hept-5-en-2-ol
| Molecular Weight | 218.34 | nRot | 4 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 7 |
| Exact Molecular Weight | 218.167 | nRing | 1 |
| Solubility: LogS | -4.109 | nHRing | 0 |
| Solubility: LogP | 4.241 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.759 |
| Synth | 2.717 |
| Natural Product Likeliness | 1.001 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.713 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.389 |
| MDCK | 0.0000159 |
| BBB | 0.198 |
| PPB | 0.944914 |
| VDSS | 2.913 |
| FU | 0.0776024 |
| CYP1A2-inh | 0.838 |
| CYP1A2-sub | 0.626 |
| CYP2c19-inh | 0.832 |
| CYP2c19-sub | 0.886 |
| CYP2c9-inh | 0.449 |
| CYP2c9-sub | 0.826 |
| CYP2d6-inh | 0.37 |
| CYP2d6-sub | 0.392 |
| CYP3a4-inh | 0.259 |
| CYP3a4-sub | 0.556 |
| CL | 13.028 |
| T12 | 0.097 |
| hERG | 0.03 |
| Ames | 0.007 |
| ROA | 0.011 |
| SkinSen | 0.311 |
| Carcinogencity | 0.091 |
| EI | 0.953 |
| Respiratory | 0.012 |
| NR-Aromatase | 0.03 |
| Antiviral | Yes |
| Prediction | 0.828806 |